Context Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Context Therapeutics Inc. (CNTX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents94.4314.4035.5049.640.29
Cash & Short-Term Investments94.4314.4035.5049.640.29
Accounts Receivable0.000.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets3.471.602.360.370.01
Total Current Assets97.9016.0537.8551.260.30
Non-Current Assets
Property, Plant & Equipment (Net)0.230.020.080.000.00
Other Non-Current Assets0.000.000.030.050.05
Total Non-Current Assets0.230.020.110.050.00
Total Assets98.1316.0637.9751.310.47
Current Liabilities
Accounts Payable1.454.193.153.032.71
Short-Term Debt0.110.000.000.000.06
Current Portion of Long-Term Debt0.000.000.000.000.06
Accrued Liabilities1.141.802.130.680.96
Other Current Liabilities1.190.650.770.440.00
Total Current Liabilities2.754.193.213.039.55
Non-Current Liabilities
Long-Term Debt0.110.000.000.000.07
Other Non-Current Liabilities0.000.000.000.000.03
Total Non-Current Liabilities0.110.000.000.000.00
Total Liabilities2.864.193.213.039.65
Stockholders' Equity
Common Stock0.090.020.020.020.00
Retained Earnings-94.78-68.10-44.09-29.25-18.80
Additional Paid-in Capital189.9679.9178.8377.510.00
Shares Outstanding89.7015.9715.9715.970.00
Total Stockholders' Equity95.2711.8334.7648.27-9.18
Total Liabilities & Equity98.1316.0637.9751.310.00